Altered amino acid metabolism and potential drugs in DLBCL
Altered amino acid metabolism and potential drugs in DLBCL. Glutamine is transported by glutamine transporters and then converted into glutamate by GLS. SIRT3 stimulates glutamine dissolution by activating GDH to increase α-KG production, which leads to enhancement of the TCA cycle and thereby generates more ATP to support tumor growth. IDO is a rate-limiting enzyme that catalyzes tryptophan to Kyn and kynurenic acid, which are considered immunosuppressive. PRMT5 promotes transcription of MYC. MYC activates GLS and glutamine transporters. HBP activates the NF-κB signaling pathway. The HBP inhibitor azaserine in DLBCL cells can inhibit the activation of NF-κB, and thereby induce cell arrest and apoptosis. BPTES is a selective allosteric regulator of GLS1 that attenuates the growth of lymphoma xenografts and delays MYC-driven tumor proliferation. Another GLS inhibitor, CB-839 inhibits the conversion of glutamine to glutamate. Kyn, catalyzed by IDO1 from tryptophan, is considered immunosuppressive. Molecules in red represent upregulation in DLBCL. GLS: glutaminase; SIRT3: NAD-dependent deacetylase sirtuin-3; PRMT5: protein arginine methyltransferase-5; HBP: the hexosamine biosynthesis pathway; ATP: adenosine triphosphate; TCA: tricarboxylic acid; GDH: glutamate dehydrogenase; α-KG: α-ketoglutarate; Kyn: kynurenine; NF-κB: nuclear factor kappa-B
Publication
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma (2023) Jianbo Wu, et al. Metabolites. 2023 Jun;13(6). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | HBP | HBP | ncbigene_synonym | AZU1 | 566 |
| Homo sapiens | Primates | HBP | HBP | ncbigene_synonym | HDLBP | 3069 |
| Homo sapiens | Primates | HBP | HBP | ncbigene_synonym | SLBP | 7884 |
| Homo sapiens | Primates | HBP | HBP | ncbigene_synonym | STAM2 | 10254 |
| Homo sapiens | Primates | HBP | HBP | ncbigene_synonym | HEBP1 | 50865 |
| Homo sapiens | Primates | NFKB | NFKB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | NFKB | NFKB | famplex_relations | RELA | 5970 |
| Homo sapiens | Primates | NFKB | NFKB | famplex_relations | RELB | 5971 |
| Homo sapiens | Primates | NFKB | NFKB | famplex_relations | REL | 5966 |
| Homo sapiens | Primates | NFKB | NFKB | famplex_relations | NFKB2 | 4791 |
| Homo sapiens | Primates | MYC | MYC | ncbigene_symbol | MYC | 4609 |
| Homo sapiens | Primates | PRMT5 | PRMT5 | ncbigene_symbol | PRMT5 | 10419 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_symbol | GLS | 2744 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_synonym | GLS2 | 27165 |
| Homo sapiens | Primates | IDO | IDO | ncbigene_synonym | IDO1 | 3620 |
| Homo sapiens | Primates | GDH | GDH | ncbigene_synonym | GLUD1 | 2746 |
| Homo sapiens | Primates | GDH | GDH | ncbigene_synonym | UGDH | 7358 |
| Homo sapiens | Primates | GDH | GDH | ncbigene_synonym | H6PD | 9563 |
| Homo sapiens | Primates | GDH | GDH | ncbigene_synonym | CRYL1 | 51084 |
| Homo sapiens | Primates | SIRT3 | SIRT3 | ncbigene_symbol | SIRT3 | 23410 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Azaserine | azaserine | O-(diazoacetyl)-L-serine | chebi:74846 | |
| Glutamine | GLUTAMINE | L-glutamine | chebi:18050 | |
| Tryptophan | tryptophan | (2S)-2-azaniumyl-3-(1H-indol-3-yl)propanoate | chebi:57912 | |
| CB-839 | CB-839 | chebi:231605 | ||
| IDO | Ido | ido-hexose | chebi:37709 | |
| Oxaloacetate | oxaloacetate | 2-oxobutanedioate | chebi:16452 | |
| TCA | TCA | trichloroacetic acid | chebi:30956 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|